WEDNESDAY, Jan. 4 (HealthDay News) — Physicians need to take care when prescribing seizure medication to HIV/AIDS patients to prevent harmful interactions between drugs, experts warn.
The cautionary note from the American Academy of Neurology (AAN) has led to the issuance of a new AAN guideline, which was developed in consultation with the International League Against Epilepsy.
WEDNESDAY, Dec. 21 (HealthDay News) — Approval for the HIV drug Isentress (raltegravir) has been expanded to include children and adolescents ages 2-18, the U.S. Food and Drug Administration said Wednesday.
The drug is an integrase strand transfer inhibitor that helps slow the spread of the AIDS-causing virus throughout the body, the agency said in a news release. It was first approved for adults in October 2007.
WEDNESDAY, Dec. 14 (HealthDay News) –
Headache affects 50 percent of HIV/AIDS patients in the United States, and many of those headaches are severe, a new study says.
About 27.5 percent of the 200 HIV/AIDS patients in the study suffered “chronic migraine,” a rare condition in which a person has migraine symptoms (with or without other headaches) for 15 or more days a month. This condition occurs in only 2 percent of the general population.
By Dennis Thompson
HealthDay Reporter
THURSDAY, Dec. 1 (HealthDay News) — For many it’s a good news/bad news scenario.
People with HIV/AIDS are living longer and healthier lives than ever before, but they still have a chronic disease that’s potentially fatal and carries a heavy stigma, said Jorie Barna, a care coordinator for the AIDS/HIV Services Group in Charlottesville, Va.
By Dennis Thompson
HealthDay Reporter
THURSDAY, Dec. 1 (HealthDay News) — The data may at first seem dire: More people are living with HIV/AIDS than ever before in the United States, according to the U.S. Centers for Disease Control and Prevention.
But researchers say that’s actually good news because people are living with the disease through effective medical treatment, rather than dying from its relentless progress.
WEDNESDAY, Nov. 30 (HealthDay News) — Toddlers who take anti-HIV drugs have higher cholesterol levels than those who do not have HIV, a new study shows.
It’s the first such finding in toddlers and the long-term significance is unknown, according to the U.S. National Institutes of Health researchers and colleagues.
By Steven Reinberg
HealthDay Reporter
WEDNESDAY, Nov. 30 (HealthDay News) — Advocates for HIV/AIDS research and treatment met Wednesday to discuss how to reduce the spread of the disease in the United States, improve access to better care and raise general awareness of the ongoing epidemic.
On Tuesday, the U.S. Centers for Disease Control and Prevention released a report on HIV in the United States revealing that 1.2 million Americans are living with HIV, yet only about 28 percent of them have their disease under control.
By Randy Dotinga
HealthDay Reporter
TUESDAY, Oct. 25 (HealthDay News) — Preliminary research suggests that a patch could deliver an AIDS drug to patients, but it’s too early to know if it could work in animals, let alone humans.
Still, the findings raise the prospect of a simple way to administer AIDS drugs, which patients don’t always take as they should. Patches could be worn for seven days, and an author of the new study said it would add only a fraction of a cent to the cost of the drug itself.
THURSDAY, Oct. 6 (HealthDay News) — Researchers have identified two genetically distinct types of HIV in the cerebrospinal fluid (CSF) of patients with HIV-associated dementia.
The discovery may help explain why the risk of developing neurological difficulties increases as AIDS patients live longer, and may also help predict which patients are at greatest risk for the problem, according to the U.S. scientists.
By Amanda Gardner
HealthDay Reporter
TUESDAY, Aug. 16 (HealthDay News) — HIV/AIDS experts gathering in Atlanta this week expressed growing concerns over a rise in rates of HIV infection among the nation’s poor and minorities.
New data released Tuesday at the National HIV Prevention Conference by the U.S. Centers for Disease Control and Prevention found that 19 percent of gay and bisexual men, 9 percent of intravenous drug users and 2 percent of low-income heterosexuals were infected with HIV. This compares with an overall infection rate in the United States of only 0.47 percent. And nearly half of people in each of these high-risk groups were unaware of their HIV status.
| Text Size: |  |
|
